Routine

Pulmonary function test interpretation

spirometry & lung volumes · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Structured interpretation of spirometry, lung volumes and gas transfer classifies disease as obstructive, restrictive or mixed and guides further work-up. Using reference equations with lower-limit-of-normal thresholds and z-scores avoids misclassification from fixed ratios.

Red flags

  • Flattened inspiratory/expiratory loop suggesting upper-airway obstruction
  • Rapidly falling FEV1 or FVC on serial testing
  • Isolated low DLCO (consider pulmonary vascular disease)
  • Severe reduction prompting urgent evaluation

Assessment

Differential diagnosis

  • Obstructive disease (asthma, COPD, bronchiectasis)
  • Restrictive disease (ILD, chest wall, neuromuscular)
  • Mixed obstructive-restrictive disease
  • Pulmonary vascular disease (isolated low DLCO)
  • Normal variant / poor technique

Investigations

  • Spirometry (FEV1, FVC, FEV1/FVC) pre and post bronchodilator
  • Static lung volumes (TLC, RV) by plethysmography/gas dilution
  • Diffusing capacity (DLCO, KCO)
  • Flow-volume loop shape assessment
  • Reference equations (e.g. GLI) with lower limit of normal / z-scores

Management

  • Check test quality and reproducibility before interpreting
  • Assess FEV1/FVC against the lower limit of normal to detect obstruction (not a fixed 0.70 alone)
  • If obstructed, grade severity by FEV1 % predicted and assess bronchodilator response
  • If FEV1/FVC is preserved but FVC is low, measure lung volumes to confirm restriction
  • Confirm restriction with a reduced TLC
  • Interpret DLCO: reduced in emphysema, ILD and pulmonary vascular disease; raised in asthma/haemorrhage
  • Examine the flow-volume loop for upper-airway obstruction patterns
  • Integrate with symptoms, imaging and history for a clinical diagnosis
  • Use serial testing to track disease progression and treatment response
  • Avoid over-reliance on a single ratio — interpret the whole pattern

Drugs & doses

Bronchodilator for reversibility testing: salbutamol 400 mcg via spacer, reassess at 15 min
No therapeutic drug; results guide disease-specific treatment
Withhold bronchodilators appropriately before reversibility testing

Disposition

Respiratory physiology/clinic; results direct disease-specific investigation and management.

Complications & pitfalls

  • Misclassification from using a fixed FEV1/FVC ratio
  • Missed restriction when only spirometry is performed
  • Overdiagnosis of COPD in older patients using fixed ratios
  • Poor-quality tests leading to wrong conclusions

Exam pearls

  • Use the lower limit of normal / z-scores (GLI equations) rather than fixed cut-offs to avoid age-related misclassification
  • Spirometry cannot diagnose restriction — you need lung volumes (TLC)
  • A low KCO with low DLCO points to parenchymal/vascular disease; a preserved KCO suggests extrapulmonary restriction
  • Always check test quality before interpreting numbers

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.